Phenotypic resistance testing

Scandinavian Journal of Infectious Diseases, Supplement

Volumn , Issue 106, 2003, Pages 35-36

  Andreoni, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZALCITABINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; AUTOMATION; DRUG SENSITIVITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PHENOTYPE; QUANTITATIVE ANALYSIS; TISSUE CULTURE; VALIDATION PROCESS; VIRUS CHARACTERIZATION; VIRUS REPLICATION; VIRUS RESISTANCE; ANTIBIOTIC RESISTANCE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY;

ANTI-HIV AGENTS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 1242321018     PISSN: 03008878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Kempf D, Brun S, Rode R, Isaacson J, King M, Xu Y, et al. Identification of clinically relevant phenotypic and genotypic breakpoints for ABT-378/r in multiple PI-experienced, NNRTI-naive patients. Antiviral Ther 2000; 5 (Suppl 3): 70. Abstract 89.
2. Kuritzkes DR, Sevin A, Young B, Bakhtiari M, Wu H, St Clair M, et al. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine/lamivudine/ritonavir: Genotypic analysis of HIV-1 isolates from ACTG 315. J Infect Dis 2000; 181: 491-7.
3. Larder BA, Kemp SD, Hertogs K. Quantitative prediction of HIV-1 phenotypic drug resistance from genotypes: the virtual phenotype (VirtualPhenotype). Antiviral Ther 2000; 5 (Suppl 3): 49. Abstract 63.
4. Graham N, Peeters M, Verbiest W, Harrigan R, Larder B. The Virtual Phenotype is an independent predictor of clinical response. Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections, 4-8 February 2001, Chicago, USA. Abstract 524.
5. Parkin NT, Chappey C, Maroldo L, Arocha J, Fralich T, Schrader S, et al. Incidence and nature of phenotype-genotype discordance: maximizing the utility of resistance testing. Programme and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections, 24-28 February 2002, Seattle, USA. Abstract 580.
6. Sarmati L, Nicastri E, Parisi SG, D'Ettorre G, Mancino G, Narciso P, et al. Discordance between genotypic and phenotypic drug resistance profiles in HIV-1 strains isolated from peripheral mononuclear cells. J Clin Microbiol 2002; 40: 335-40.